Inotiv (NOTVQ) EBIT Growth (3y) (2013 - 2026)
Inotiv (NOTVQ) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.04% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 12.85% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.37% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -1.16% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.23% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 68.50% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.10% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.67% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | -108.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.67% |
| Dec 31, 2025 | 43.51% |
| Sep 30, 2025 | 69.64% |
| Jun 30, 2025 | -47.14% |
| Mar 31, 2025 | -33.39% |
| Dec 31, 2024 | 22.75% |
| Sep 30, 2024 | -56.91% |
| Jun 30, 2024 | -130.12% |
| Mar 31, 2024 | -335.78% |
| Dec 31, 2023 | -775.62% |
| Sep 30, 2023 | 55.97% |
| Jun 30, 2023 | 173.30% |
| Mar 31, 2023 | -121.70% |
| Dec 31, 2022 | -346.14% |
| Sep 30, 2022 | -684.65% |
| Jun 30, 2022 | 176.54% |
| Mar 31, 2022 | 169.27% |
| Dec 31, 2021 | -836.95% |
| Sep 30, 2021 | -256.84% |
| Jun 30, 2021 | -276.14% |